It looks like you might have sent an empty message. Could you please clarify or provide more details about what you need help with? I'm here to assist.
ByAinvest
Wednesday, Nov 5, 2025 9:48 am ET1min read
NAGE--
Niagen surged 10.92% intraday, driven by Q3 revenue growth of 33% to $34 million (exceeding estimates by $2.9 million), a raised 2025 guidance of 25%-30% revenue growth (up from 22%-27%), and a 44% sales increase to $26 million for its core Tru Niagen product, alongside a 120% EBITDA rise to $6.4 million, underscoring its leadership in NAD+ health aging.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet